Skip to main content
Premium Trial:

Request an Annual Quote

Get While the Gettin's Good

Two years after Pfizer closed its 175-acre research complex in Ann Arbor, the University of Michigan has bought it for $108 million. "The price was right," says Stephen Forrest, vice president for research, in an article at The Chronicle of Higher Education. The university hopes to expand its research programs, possibly creating at least 2,000 new jobs over the next decade. Most of the money to acquire the site will come from the University of Michigan Health System's reserves; the rest will come from the university's investments, says the story.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.